Lipoprotein disorders classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Template:DiseaseDisorder infobox

Lipoprotein Disorders Microchapters
Patient Information
Overview
Causes
Classification Hyperlipoproteinemia Hypolipoproteinemia
Treatment

Overview

Hyperlipidemias are classified according to the Fredrickson classification which is based on the pattern of lipoproteins on electrophoresis or ultracentrifugation. It was later adopted by the World Health Organization (WHO). It does not directly account for HDL, and it does not distinguish among the different genes that may be partially responsible for some of these conditions. It remains a popular system of classification, but is considered dated by many.

Classification

Fredrickson classification of Hyperlipidemias

Hyperlipoproteinemia	Synonyms	Problems	Labs description	Treatment
Type I	Buerger-Gruetz syndrome, Primary hyperlipoproteinaemia, or Familial hyperchylomicronemia	Decreased lipoprotein lipase (LPL) or altered ApoC2	Elevated Chylomicrons	Diet Control
Type IIa	Polygenic hypercholesterolaemia or Familial hypercholesterolemia	LDL receptor deficiency	Elevated LDL only	Bile Acid Sequestrants, Statins, Niacin
Type IIb	Combined hyperlipidemia	Decreased LDL receptor and Increased ApoB	Elevated LDL, VLDL and Triglycerides	Statins, Niacin, Gemfibrozil
Type III	Familial Dysbetalipoproteinemia	Defect in ApoE synthesis	Increased IDL	Drug of choice: Gemfibrozil
Type IV	Endogenous Hyperlipemia	Increased VLDL production and Decreased elimination	Increased VLDL	Drug of choice: Niacin
Type V	Familial Hypertriglyceridemia	Increased VLDL production and Decreased LPL	Increased VLDL and Chylomicrons	Niacin, Gemfibrozil

Unclassified forms

Non-classified forms are extremely rare:

• Hypo-alpha lipoproteinemia
• Hypo-beta lipoproteinemia (prevalence 0.01-0.1%)

External links

• The Fredrickson papers (with photos from early lipoprotein research)

Template:WikiDoc Sources